
EMCUREEmcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Q2 FY27 Results: Consolidated Net Profit ₹325 Crore on Total Income of ₹2,824 Crore
Emcure Pharmaceuticals (NSE: EMCURE) reported consolidated total income of ₹2,823.73 crore and net profit of ₹325.07 crore for the quarter ended 30 Sep 2026, it said in a filing on 03 Nov 2026. Standalone total income was ₹1,701.52 crore and standalone net profit ₹248.43 crore for the same quarter.
- Earnings
- pharmaceuticals